nach oben

Breast Cancer Research

Erschienen in:

01.05.2008 | Poster presentation

Diagnosed with breast cancer whilst on a family history screening programme: an exploratory qualitative study

verfasst von: A Clements, B Henderson, S Tyndel, G Evans, K Brain, E Watson, J Austoker, the Management Group

Erschienen in: Breast Cancer Research | Sonderheft 2/2008

Einloggen, um Zugang zu erhalten

Excerpt

Early mammographic screening (under the age of 50) is offered to many women in the UK who are at moderate or high risk of developing breast cancer because of their family history of the disease [1]. While studies are underway to establish the clinical effectiveness of early mammographic screening [2], relatively little is understood about the impact of early and regular surveillance on the psychological wellbeing of women [3], and even less about the impact of being diagnosed with breast cancer while on a screening programme. This qualitative study explores the emotional effect that the diagnosis of breast cancer had on women, and the value they placed on having joined the family history screening programme, both pre and post diagnosis. …

NICE. [http://www.nice.org.uk/guidance/CG41]

The FH01 Management Committee, Steering Committee and Collaborators: The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. J Med Screen. 2006, 13: 177-182.

Tyndel S, Austoker J, Henderson B, et al: What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS Management Group. J Clin Oncol. 2007, 25: 3823-3829. 10.1200/JCO.2007.11.0437.CrossRefPubMed

Titel: Diagnosed with breast cancer whilst on a family history screening programme: an exploratory qualitative study
verfasst von: A Clements
B Henderson
S Tyndel
G Evans
K Brain
E Watson
J Austoker
the Management Group
Publikationsdatum: 01.05.2008
Verlag: BioMed Central
Erschienen in: Breast Cancer Research / Ausgabe Sonderheft 2/2008
Elektronische ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr1973

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Diagnosed with breast cancer whilst on a family history screening programme: an exploratory qualitative study

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2008

PARP-1 inhibitor monotherapy and combination therapy in a preclinical mouse model of Brca2 mutant breast cancer

Role of poly(ADPribosyl)ation of CTCF in cancer and normal breast cells

Association of gene variants in the TGF-beta signalling pathways with invasive breast cancer risk

Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?

Inhibition of apoptosis by Notch signalling in breast epithelial cells

Regulation of cyclin D1by the BRCA1–BARD1 complex

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie